PROVAXS, your partner for innovation in animal health
PROVAXS facilitates interaction and collaboration between industry and Ghent University’s experts in infectious diseases and immunity in animal health.
We offer in depth academic expertise and research capacity on selected animal pathogens and the interaction with their host.
We are open for all kinds of collaboration with our partners:
• PhD research with industrial applications
• R&D-collaboration
• Outlicensing/co-development
• Services
Find out moreNews & Events
- 5 Maart 2020 | Leidt het gebruik van desinfectiemiddelen in de veehouderij tot selectie van antimicrobiële resistentie?
- 25 February 2020 | Toxoplasma gondii infection kinetics and immune responses following infection and vaccination
- 7 January 2020 | Preclinical development of a self-replicating mRNA vaccine against Zika Virus
- 20 December 2019 | Intradermal delivery strategies of mRNA-based therapeutics in mice and pigs
- 19 December 2019 | Evaluation of passive and active immunisation strategies to control Campylobacter infections in broiler chickens
Navigation
Business
Contact
Dr. ir. Sven Arnouts / Business Developer
Center for Strategic Prophylaxis and Vaccine Development - PROVAXS
Ghent University / Faculty of Veterinary Medicine
Department of Virology, Parasitology and Immunology
Salisburylaan 133, 9820 Merelbeke, Belgium
Tel. : +32 495.707.334
Sven.Arnouts@UGent.be
Realisatie en beheer UCS bvba
